Nanomedicine market to reach $786.46 billion by 2030 at 16.0% cagr, driven by rising burden of complex and chronic diseases across the globe.
Read More
Nanomaterials in personalized medicine market to reach $674.28 billion by 2030 at 11.3% cagr, driven by increasing demand for personalized medicine and targeted therapeutic solutions.
Read More
Meningococcal vaccines market to reach $6.58 billion by 2030 at 9.1% CAGR, driven by increase in healthcare spending.
Read More
Memantine hcl market to reach $1.71 billion by 2030 at 6.7% CAGR, driven by rising incidence of alzheimer’s disease and growing demand for personalized medicine.
Read More
Nanocarriers market to reach $26.74 billion by 2030 at 18.1% cagr, driven by rising demand for personalized medicines and advanced drug delivery technologies.
Read More
Naloxone spray market to reach $2428.63 billion by 2030 at 24.6% cagr, driven by increasing demand for telemedicine and rapid response to opioid overdose cases.
Read More
Melatonin supplements market to reach $4.89 billion by 2030 at 12.2% CAGR, driven by rising prevalence of sleep disorders.
Read More
Myeloproliferative disorders drugs market to reach $12.17 billion by 2030 at 4.6% cagr, driven by rise in incidence of myeloproliferative disorders and aging population.
Read More
Myelodysplastic syndrome drugs market to reach $3.84 billion by 2030 at 9.6% cagr, driven by rising demand for personalized medicine and genomics-based treatment approaches.
Read More
Melanoma therapeutics market to reach $7.49 billion by 2030 at 11.0% CAGR, driven by increasing incidence of melanoma.
Read More